Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Analysis of Breast Tissue Calcifications using FTIR Spectroscopy

Not Accessible

Your library or personal account may give you access


Microalcifications can be found in both benign and malignant breast lesions and their composition can indicate the disease state. Type I microcalcifications are composed of calcium oxalate dihydrate (COD) and are associated mainly with benign tissue, whereas hydroxyapatite (HAP) can be present in both tissue types. As current practices such as mammography and histopathology examine the morphology of the specimen, they can not reliably distinguish between the two types of calcification, which frequently are the only mammographie features that indicate the presence of a cancerous lesion.

Analysis of tissue by Fourier transform infrared microspectroscopy (FTIR) allows biochemical information to be achieved from the sample. Spectral maps have been carried out on paraffinized sections of breast tissue from 9 patients of different pathology types containing calcification. The chemical composition of the calcifications and surrounding tissue has been analysed and correlated with tissue pathology. This preliminary study has demonstrated the ability to conduct FTIR in paraffinized sections of breast tissue, and initial observations show a correlation between HAP carbonate substitution and tissue pathology.

It is hoped that this and further studies will give insight into how the calcifications are linked to the disease process and will give an increased understanding of the significance of calcifications in breast tissue. If type II microcalcifications can be differentiated in benign and malignant tissue by spectroscopic techniques, this may have positive implications in early diagnosis if the techniques can be applied in vivo and spectroscopy of paraffin sections enables biochemical information to accompany histopathology of the sample.

© 2007 SPIE

PDF Article
More Like This
Spectroscopic tools for the elucidation of disease specific changes in breast cancer

Pascaline Bouzy, Francesca Palombo, and Nicholas Stone
JSIII_P_4 European Quantum Electronics Conference (EQEC) 2017

FTIR biochemical imaging of the prostate: an in-vitro proof of concept study

JJ Aning, M Isabelle, J Uff, AWS Ritchie, HW Gilbert, and N Stone
6628_15 European Conference on Biomedical Optics (ECBO) 2007

Detecting Breast Cancer Using Raman Spectroscopy

A.S. Haka, K.E. Shafer-Peltier, M. Fitzmaurice, J. Crowe, R.R. Dasari, and M.S. Feld
ME5 Biomedical Topical Meeting (BIOMED) 2002

Select as filters

Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All Rights Reserved